New Studies: BTK Inhibitor
A BTK inhibitor is an experimental therapy that blocks Bruton’s tyrosine kinase (BTK). BTK is an enzyme that activates certain immune cells that play a major role in the response that damages the brain and spinal cord in multiple sclerosis. It’s taken by mouth as a tablet. Read all about BTK inhibitors.
Two new studies are recruiting people with primary progressive or secondary progressive MS, testing the effectiveness of orelabrutinib, a BTK inhibitor. Click the links above to find out more about these studies and recruiting locations.
More info on primary progressive study: www.nationalmssociety.org/how-you-can-help/get-involved/part...
More info on secondary progressive study: www.nationalmssociety.org/how-you-can-help/get-involved/part...
